Long-term management of Kawasaki disease: Implications for the adult patient

Pediatrics and Neonatology

Volumn 54, Issue 1, 2013, Pages 12-21

  Manlhiot, Cedric ^a   Niedra, Elizabeth ^a   McCrindle, Brian W ^a  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

Author keywords

cardiovascular risk; coronary artery aneurysms; Kawasaki disease; long term management

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN RECEPTOR; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; IMMUNOGLOBULIN; LOW MOLECULAR WEIGHT HEPARIN; NITRATE; SERUM ALBUMIN; WARFARIN;

AORTA VALVE REGURGITATION; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CAROTID ATHEROSCLEROSIS; CORONARY ARTERY ANEURYSM; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE DURATION; DRUG MEGADOSE; ENDOCARDITIS; ENDOTHELIAL DYSFUNCTION; FEVER; FOLLOW UP; HEALTH CARE SYSTEM; HEART INFARCTION; HEART MUSCLE FIBROSIS; HEART VENTRICLE ARRHYTHMIA; HUMAN; ISCHEMIC HEART DISEASE; LONG TERM CARE; LOW DRUG DOSE; MITRAL VALVE DISEASE; MITRAL VALVE REGURGITATION; MUCOCUTANEOUS LYMPH NODE SYNDROME; MYOCARDITIS; REVASCULARIZATION; REVIEW; STENOSIS; SUDDEN DEATH; THROMBOSIS; TRANSIENT ISCHEMIC ATTACK; TREATMENT DURATION; VALVULAR HEART DISEASE;

ADULT; ATHEROSCLEROSIS; CORONARY ANEURYSM; FOLLOW-UP STUDIES; HUMANS; MUCOCUTANEOUS LYMPH NODE SYNDROME;

EID: 84875214030     PISSN: 18759572     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pedneo.2012.12.013     Document Type: Review

References (63)

1. W.M. Gersony The adult after Kawasaki disease the risks for late coronary events J Am Coll Cardiol 54 2009 1921 1923
2. J.B. Gordon, A.M. Kahn, and J.C. Burns When children with Kawasaki disease grow up myocardial and vascular complications in adulthood J Am Coll Cardiol 54 2009 1911 1920
3. J.M. Orenstein, S.T. Shulman, L.M. Fox, S.C. Baker, M. Takahashi, and T.R. Bhatti Three linked vasculopathic processes characterize Kawasaki disease: a light and transmission electron microscopic study PLoS One 7 2012 e38998
4. S. Blankier, B.W. McCrindle, S. Ito, and R.S. Yeung The role of atorvastatin in regulating the immune response leading to vascular damage in a model of Kawasaki disease Clin Exp Immunol 164 2011 193 201
5. B.W. McCrindle Kawasaki disease: a childhood disease with important consequences into adulthood Circulation 120 2009 6 8
6. J.W. Newburger, M. Takahashi, M.A. Gerber, M.H. Gewitz, L.Y. Tani, and J.C. Burns Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association Circulation 110 2004 2747 2771
7. M.A. Crystal, S.K. Syan, R.S. Yeung, A.I. Dipchand, and B.W. McCrindle Echocardiographic and electrocardiographic trends in children with acute Kawasaki disease Can J Cardiol 24 2008 776 780
8. J.W. Newburger, M. Takahashi, A.S. Beiser, J.C. Burns, J. Bastian, and K.J. Chung A single intravenous infusion of gamma globulin as compared with four infusions in the treatment of acute Kawasaki syndrome N Engl J Med 324 1991 1633 1639
9. H. Kato, E. Ichinose, F. Yoshioka, T. Takechi, S. Matsunaga, and K. Suzuki Fate of coronary aneurysms in Kawasaki disease: serial coronary angiography and long-term follow-up study Am J Cardiol 49 1982 1758 1766
10. H. Kato, T. Sugimura, T. Akagi, N. Sato, K. Hashino, and Y. Maeno Long-term consequences of Kawasaki disease. A 10- to 21-year follow-up study of 594 patients Circulation 94 1996 1379 1385
11. V.E. Honkanen, B.W. McCrindle, R.M. Laxer, B.M. Feldman, R. Schneider, and E.D. Silverman Clinical relevance of the risk factors for coronary artery inflammation in Kawasaki disease Pediatr Cardiol 24 2003 122 126
12. M. Takahashi, W. Mason, and A.B. Lewis Regression of coronary aneurysms in patients with Kawasaki syndrome Circulation 75 1987 387 394
13. C. Manlhiot, R.S. Yeung, N.A. Clarizia, N. Chahal, and B.W. McCrindle Kawasaki disease at the extremes of the age spectrum Pediatrics 124 2009 e410 e415
14. T. Sabharwal, C. Manlhiot, S.M. Benseler, P.N. Tyrrell, N. Chahal, and R.S. Yeung Comparison of factors associated with coronary artery dilation only versus coronary artery aneurysms in patients with Kawasaki disease Am J Cardiol 104 2009 1743 1747
15. L.A. Sleeper, L.L. Minich, B.M. McCrindle, J.S. Li, W. Mason, and S.D. Colan Evaluation of Kawasaki disease risk-scoring systems for intravenous immunoglobulin resistance J Pediatr 158 2011 831 835.e3
16. Y.T. Lin, C. Manlhiot, J.C. Ching, R.K. Han, L.E. Nield, and R. Dillenburg Repeated systematic surveillance of Kawasaki disease in Ontario from 1995 to 2006 Pediatr Int 52 2010 699 706
17. C. Manlhiot, K. Millar, F. Golding, and B.W. McCrindle Improved classification of coronary artery abnormalities based only on coronary artery z-scores after Kawasaki disease Pediatr Cardiol 31 2010 242 249
18. K. Millar, C. Manlhiot, R.S. Yeung, Z. Somji, and B.W. McCrindle Corticosteroid administration for patients with coronary artery aneurysms after Kawasaki disease may be associated with impaired regression Int J Cardiol 154 2012 9 13
19. M. Iemura, M. Ishii, T. Sugimura, T. Akagi, and H. Kato Long term consequences of regressed coronary aneurysms after Kawasaki disease: vascular wall morphology and function Heart 83 2000 307 311
20. JCS Joint Working Group Guidelines for diagnosis and management of cardiovascular sequelae in Kawasaki disease (JCS 2008) - digest version Circ J 74 2010 1989 2020
21. M.A. Crystal, C. Manlhiot, R.S. Yeung, J.F. Smallhorn, and B.W. McCrindle Coronary artery dilation after Kawasaki disease for children within the normal range Int J Cardiol 136 2009 27 32
22. A.H. Rowley, and S.T. Shulman Kawasaki syndrome Clin Microbiol Rev 11 1998 405 414
23. J.P. Strong The natural history of atherosclerosis in childhood Ann N Y Acad Sci 623 1991 9 15
24. P. Angelini, and J. Monge Newer concepts regarding adults with coronary artery aneurysms: are they all Kawasaki? Does it make a difference? Circulation 125 2012 3076 3078
25. T. Sugimura, H. Yokoi, N. Sato, T. Akagi, T. Kimura, and M. Iemura Interventional treatment for children with severe coronary artery stenosis with calcification after long-term Kawasaki disease Circulation 96 1997 3928 3933
26. Y. Mitani, H. Sawada, H. Hayakawa, K. Aoki, H. Ohashi, and M. Matsumura Elevated levels of high-sensitivity C-reactive protein and serum amyloid-A late after Kawasaki disease: association between inflammation and late coronary sequelae in Kawasaki disease Circulation 111 2005 38 43
27. S. Kaichi, E. Tsuda, H. Fujita, K. Kurosaki, R. Tanaka, and H. Naito Acute coronary artery dilation due to Kawasaki disease and subsequent late calcification as detected by electron beam computed tomography Pediatr Cardiol 29 2008 568 573
28. A. Suzuki, S. Miyagawa-Tomita, M. Nakazawa, and C. Yutani Remodeling of coronary artery lesions due to Kawasaki disease: comparison of arteriographic and immunohistochemical findings Jpn Heart J 41 2000 245 256
29. C. Manlhiot, L.R. Brandão, Z. Somji, A.L. Chesney, C. MacDonald, and R.C. Gurofsky Long-term anticoagulation in Kawasaki disease: initial use of low molecular weight heparin is a viable option for patients with severe coronary artery abnormalities Pediatr Cardiol 31 2010 834 842
30. D.M. Levy, E.D. Silverman, M.P. Massicotte, B.W. McCrindle, and R.S. Yeung Longterm outcomes in patients with giant aneurysms secondary to Kawasaki disease J Rheumatol 32 2005 928 934
31. K. Suda, M. Iemura, H. Nishiono, Y. Teramachi, Y. Koteda, and S. Kishimoto Long-term prognosis of patients with Kawasaki disease complicated by giant coronary aneurysms: a single-institution experience Circulation 123 2011 1836 1842
32. N. Noto, T. Okada, M. Yamasuge, K. Taniguchi, K. Karasawa, and M. Ayusawa Noninvasive assessment of the early progression of atherosclerosis in adolescents with Kawasaki disease and coronary artery lesions Pediatrics 107 2001 1095 1099
33. N. Noto, T. Okada, K. Karasawa, M. Ayusawa, N. Sumitomo, and K. Harada Age-related acceleration of endothelial dysfunction and subclinical atherosclerosis in subjects with coronary artery lesions after Kawasaki disease Pediatr Cardiol 30 2009 262 268
34. M. Albisetti, A.K. Chan, B.W. McCrindle, D. Wong, P. Vegh, and M. Adams Fibrinolytic response to venous occlusion is decreased in patients after Kawasaki disease Blood Coagul Fibrinolysis 14 2003 181 186
35. B.W. McCrindle, S. McIntyre, C. Kim, T. Lin, and K. Adeli Are patients after Kawasaki disease at increased risk for accelerated atherosclerosis? J Pediatr 151 2007 244 248 248.e1
36. K. Hamaoka, and Z. Onouchi Effects of coronary artery aneurysms on intracoronary flow velocity dynamics in Kawasaki disease Am J Cardiol 77 1996 873 875
37. K. Hamaoka, Z. Onouchi, Y. Kamiya, and K. Sakata Evaluation of coronary flow velocity dynamics and flow reserve in patients with Kawasaki disease by means of a Doppler guide wire J Am Coll Cardiol 31 1998 833 840
38. T. Ohkubo, R. Fukazawa, E. Ikegami, and S. Ogawa Reduced shear stress and disturbed flow may lead to coronary aneurysm and thrombus formations Pediatr Int 49 2007 1 7
39. J.W. Newburger, J.C. Burns, A.S. Beiser, and J. Loscalzo Altered lipid profile after Kawasaki syndrome Circulation 84 1991 625 631
40. Y.F. Cheung, T.C. Yung, S.C. Tam, M.H. Ho, and A.K. Chau Novel and traditional cardiovascular risk factors in children after Kawasaki disease: implications for premature atherosclerosis J Am Coll Cardiol 43 2004 120 124
41. L. Banks, Y.T. Lin, N. Chahal, C. Manlhiot, R.S. Yeung, and B.W. McCrindle Factors associated with low moderate-to-vigorous physical activity levels in pediatric patients with Kawasaki disease Clin Pediatr (Phila) 51 2012 828 834
42. N. Chahal, N.A. Clarizia, B.W. McCrindle, K.M. Boydell, M. Obadia, and C. Manlhiot Parental anxiety associated with Kawasaki disease in previously healthy children J Pediatr Health Care 24 2010 250 257
43. R. Fukazawa Long-term prognosis of Kawasaki disease: increased cardiovascular risk? Curr Opin Pediatr 22 2010 587 592
44. R. Dalla Pozza, S. Bechtold, S. Urschel, R. Kozlik-Feldmann, and H. Netz Subclinical atherosclerosis, but normal autonomic function after Kawasaki disease J Pediatr 151 2007 239 243
45. W.J. Ravekes, S.D. Colan, K. Gauvreau, A.L. Baker, R.P. Sundel, and M.E. van der Velde Aortic root dilation in Kawasaki disease Am J Cardiol 87 2001 919 922
46. H. Nakano, K. Nojima, A. Saito, and K. Ueda High incidence of aortic regurgitation following Kawasaki disease J Pediatr 107 1985 59 63
47. C. Yutani, S. Go, T. Kamiya, O. Hirose, H. Misawa, and H. Maeda Cardiac biopsy of Kawasaki disease Arch Pathol Lab Med 105 1981 470 473
48. Y. Sakai, K. Takayanagi, T. Inoue, H. Yamaguchi, T. Hayashi, and S. Morooka Coronary artery aneurysms and congestive heart failure-possible long-term course of Kawasaki disease in an adult - a case report Angiology 39 1988 625 630
49. I.B. Kristensen, and B.O. Kristensen Sudden death caused by thrombosed coronary artery aneurysm. Two unusual cases of Kawasaki disease Int J Legal Med 106 1994 277 280
50. L. Rozin, S.A. Koehler, A. Shakir, S. Ladham, and C.H. Wecht Kawasaki disease: a review of pathologic features of stage IV disease and two cases of sudden death among asymptotic young adults Am J Forensic Med Pathol 24 2003 45 50
51. D. Takeuchi, T. Saji, S. Takatsuki, and M. Fujiwara Abnormal tissue doppler images are associated with elevated plasma brain natriuretic peptide and increased oxidative stress in acute Kawasaki disease Circ J 71 2007 357 362
52. E. Tsuda, Y. Arakaki, T. Shimizu, H. Sakaguchi, S. Yoshimura, and S. Yazaki Changes in causes of sudden deaths by decade in patients with coronary arterial lesions due to Kawasaki disease Cardiol Young 15 2005 481 488
53. J.K. Liao, and U. Laufs Pleiotropic effects of statins Annu Rev Pharmacol Toxicol 45 2005 89 118
54. Q. Zhou, and J.K. Liao Pleiotropic effects of statins. Basic research and clinical perspectives Circ J 74 2010 818 826
55. M. Essig, G. Nguyen, D. Prié, B. Escoubet, J.D. Sraer, and G. Friedlander 3-Hydroxy-3-methylglutaryl coenzyme A reductase inhibitors increase fibrinolytic activity in rat aortic endothelial cells. Role of geranylgeranylation and Rho proteins Circ Res 83 1998 683 690
56. S.M. Huang, K.P. Weng, J.S. Chang, W.Y. Lee, S.H. Huang, and K.S. Hsieh Effects of statin therapy in children complicated with coronary arterial abnormality late after Kawasaki disease: a pilot study Circ J 72 2008 1583 1587
57. C.E. Tacke, I.M. Kuipers, M. Groenink, A.M. Spijkerboer, and T.W. Kuijpers Cardiac magnetic resonance imaging for noninvasive assessment of cardiovascular disease during the follow-up of patients with Kawasaki disease Circ Cardiovasc Imaging 4 2011 712 720
58. S. Mavrogeni, G. Papadopoulos, E. Karanasios, and D.V. Cokkinos How to image Kawasaki disease: a validation of different imaging techniques Int J Cardiol 124 2008 27 31
59. T. Akagi, H. Kato, O. Inoue, N. Sato, and K. Imamura Valvular heart disease in Kawasaki syndrome: incidence and natural history Am Heart J 120 1990 366 372
60. S. Yonesaka, T. Takahashi, T. Matubara, T. Nakada, H. Furukawa, and K. Tomimoto Histopathological study on Kawasaki disease with special reference to the relation between the myocardial sequelae and regional wall motion abnormalities of the left ventricle Jpn Circ J 56 1992 352 358
61. E. Tsuda, M. Matsuo, H. Naito, T. Noguchi, H. Nonogi, and S. Echigo Clinical features in adults with coronary arterial lesions caused by presumed Kawasaki disease Cardiol Young 17 2007 84 89
62. S. Yagi, E. Tsuda, W. Shimizu, T. Kurita, O. Seguchi, and H. Nonogi Two adults requiring implantable defibrillators because of ventricular tachycardia and left ventricular dysfunction caused by presumed Kawasaki disease Circ J 69 2005 870 874
63. Z.R. Yousef, S.R. Redwood, and M.S. Marber Postinfarction left ventricular remodelling: where are the theories and trials leading us? Heart 83 2000 76 80